| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $249.3M | $254.4M | $259.0M |
| YoY Revenue Growth % | -2.0% | -1.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$105.3M | -$217.5M | -$692.1M |
| Operating Margin % | -42.2% | -80.0% | -80.0% |
| Net Income (GAAP) | -$95.7M | -$208.1M | -$675.2M |
| EBITDA (Normalized) | -$105.3M | -$217.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$66.0M | -$127.3M | -$148.3M |
| Capital Expenditures (CapEx) | $21.0K | $119.0K | — |
| Free Cash Flow (FCF) | -$66.0M | -$127.5M | -$148.3M |
| FCF Margin % | -26.5% | -50.1% | -57.3% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $182.3M | $228.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $235.6M | $304.8M | — |